A groundbreaking CRISPR tool could reverse the global antibiotic resistance crisis. Could this be the end of superbugs?

A replay of the call will be available for approximately 90 days on the Events page in the Investors & Media section of Intellia’s website, www.intelliatx.com.

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based Therapeutic to Combat Avian Flu Seek Labs, a private TechBio company building a programmable disease response platform to detect, ...

Antibiotic resistance (AR) has escalated rapidly in recent years, growing into a serious global health emergency. Disease-causing bacteria are ...

A golden apple snail can regrow a complete camera-type eye in 30 days, offering new clues into genetic pathways that may one day help restore human vision ...

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancerEVANSTON, Ill.--(BUSINESS ...

February 17, 2026 / Sciad Communications / Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...